Pacific Biosciences Of California (PACB) Raw Materials (2011 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Raw Materials of $34.7 million for Q1 2026, down 21.9% year-over-year from $44.5 million in Q1 2025, and down 10.1% quarter-over-quarter from $38.6 million in Q4 2025.
Pacific Biosciences Of California (PACB) Raw Materials (2011 - 2026) Analysis & Trends
Pacific Biosciences Of California's Raw Materials history runs 16 years deep, the most recent figure standing at $34.7 million for Q1 2026.
- In Q1 2026, Raw Materials fell 21.9% year-over-year to $34.7 million; the TTM figure through Mar 2026 stood at $34.7 million (down 21.9% YoY), while the FY2025 annual figure was $38.6 million, down 14.65% from the prior year.
- Raw Materials for Q1 2026 stood at $34.7 million, down from $38.6 million in the prior quarter.
- The five-year high for Raw Materials was $46.0 million in Q2 2025, with the low at $11.5 million in Q1 2022.
- The 5-year median for Raw Materials is $29.9 million (2024), against an average of $30.2 million.
- The sharpest annual moves came in 2022 and 2026: Raw Materials jumped 202.0% in 2022, then decreased 21.9% in 2026.
- Pacific Biosciences Of California's Raw Materials stood at $24.1 million in 2022, then jumped by 34.36% to $32.4 million in 2023, then surged by 39.58% to $45.3 million in 2024, then declined by 14.65% to $38.6 million in 2025, then decreased by 10.1% to $34.7 million in 2026.
- Business Quant data shows PACB's Raw Materials at $34.7 million in Q1 2026, $38.6 million in Q4 2025, and $41.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 396.09 Mn | 159.21 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.00 Mn |
| Mar 31, 2026 | 34.74 Mn |
| Dec 31, 2025 | 38.64 Mn |
| Sep 30, 2025 | 41.79 Mn |
| Jun 30, 2025 | 45.97 Mn |
| Mar 31, 2025 | 44.48 Mn |
| Dec 31, 2024 | 45.27 Mn |
| Sep 30, 2024 | 30.70 Mn |
| Jun 30, 2024 | 29.92 Mn |
| Mar 31, 2024 | 24.63 Mn |
| Dec 31, 2023 | 32.43 Mn |
| Sep 30, 2023 | 23.33 Mn |
| Jun 30, 2023 | 25.23 Mn |
| Mar 31, 2023 | 25.48 Mn |
| Dec 31, 2022 | 24.14 Mn |
| Sep 30, 2022 | 19.97 Mn |
| Jun 30, 2022 | 15.45 Mn |
| Mar 31, 2022 | 11.53 Mn |
| Dec 31, 2021 | 7.99 Mn |
| Jun 30, 2021 | 5.25 Mn |